Sunday, July 24, 2022 10:21:16 AM
Home»In-Focus»4 Species Of Thai Cannabis May Help Fight Cancer, Latest Studies Show
Recently conducted scientific studies show that four breeds of Thai cannabis can be efficient in stopping the cells of several kinds of cancer from multiplying. The tests were conducted on lab-grown breast, kidney, lung, colorectal, brain and pancreatic cancer cells among others.
BonnoShare this article
4 species of Thai cannabis may help fight cancer, latest studies show
The study was conducted by the Department of Medical Sciences’ Herbal Research Institute with a focus on using cannabis for medical purposes.
“These cannabis breeds are Hang Sua Sakon Nakhon TT1, Tanao Sri Kan Khao WA1, Tanao Sri Kan Daeng RD1, and Hang Karok Phu Phan ST1,” Dr Bonno, the department’s director-general, said. “They are high in tetrahydrocannabinol [THC] and cannabidiol [CBD], which can be extracted using the supercritical fluid extraction method.
4 species of Thai cannabis may help fight cancer, latest studies show
“Experiments showed that THC and CBD collected from these cannabis breeds can efficiently stop lab-grown cancer cells of various types from developing and can also help mend lesions on lab-grown lung cells,” he added. “The toxicological experiment also revealed that cannabis extracts do not cause mutagenicity in bacteria. However, they have a possibility of becoming toxic to lab-grown kidney cells, liver cells and lung cells, in descending order.”
Bonno added that these findings have been published in the department’s medical journal to exhibit the medical quality of Thai cannabis while showing the possibility for toxicity in the cells of specific organs.
“The department will go ahead with experiments on animals and then enter the clinical trial stage to ensure cannabis extracts can be safely used among cancer patients,” he added.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM